Physician profile

David Wilkett

Cardiovascular Disease · Tulsa, OK

NPI 1922080860

$24,514.28

in general payments reported to CMS, 2019-2025

46 companies · $4,922 in 2025

The $4,922 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$9,075.26
Travel and Lodging$2,410.06

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $5,934.79 2019-2025 Cardiomems, Gallant, Mitraclip
Boston Scientific Corporation $3,756.52 2019-2025 General - Therapies, Eluvia, Cds Broad Portfolio Offering
Elutia, INC. $1,768.84 2019-2024 Ecm Patch,Pouch
Novartis Pharmaceuticals Corporation $1,738.83 2019-2025 Leqvio
Ge Healthcare $1,539.41 2024-2025
Abiomed $1,369.89 2019-2024 Impella
Siemens Medical Solutions USA, INC. $1,311.62 2025 Somatom Pro.Pulse
Janssen Pharmaceuticals, INC $755.96 2019-2023 Xarelto
Impulse Dynamics (USA) INC. $600.39 2023-2025 Optimizer, Optimizer
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $557.28 2019-2025 Lifevest
Amgen INC. $466.14 2019-2024 Repatha
Merck Sharp & Dohme LLC $454.07 2021-2025 Verquvo, Capvaxive
Cathworks, INC. $394.44 2024-2025 Ffrangio
Edwards Lifesciences Corporation $363.42 2019-2022
Pfizer INC. $350.35 2019-2025
Show all 46 companies
CompanyGeneral paymentsYearsTop products
Atricure, INC. $318.32 2019-2023
Astrazeneca Pharmaceuticals LP $314.70 2019-2023 Andexxa, Brilinta
Surmodics, INC. $274.31 2023-2024 Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy
Esperion Therapeutics, INC. $209.07 2021-2022
E.R. Squibb & Sons, L.L.C. $209.06 2019-2025 Camzyos, Eliquis
Boehringer Ingelheim Pharmaceuticals, INC. $206.34 2021-2024 Jardiance
Scpharmaceuticals INC. $182.23 2024-2025
Philips North America LLC $178.20 2022-2024 (Ck4) Mcot
Penumbra, INC. $164.91 2025 Indigo System
Baxter Healthcare $159.64 2023-2025 Perclot, Hillrom - Cardiac Ambulatory Monitor, Floseal
Kestra Medical Technology Services, INC. $148.43 2025 Assure Wcd
Heartflow, INC. $140.93 2023-2024 Ffrct
Chiesi USA, INC. $98.79 2021-2022
Regeneron Healthcare Solutions, INC. $90.80 2019
Bayer Healthcare Pharmaceuticals INC. $70.05 2021-2025
Angiodynamics, INC. $50.96 2025 Alphavac
Irhythm Technologies, INC. $49.62 2022-2023 Zio Xt Patch
Getinge USA Sales, LLC $37.68 2020
Novo Nordisk INC $36.87 2023-2024 Ozempic, Rybelsus
Depuy Synthes Sales INC. $24.55 2025
W. L. Gore & Associates, INC. $23.74 2022
Lantheus Medical Imaging, INC. $21.28 2024
Amarin Pharma, INC. $20.15 2019
Inari Medical, INC. $18.02 2022
Cvrx, INC. $16.58 2023 Barostim Neo System
Medtronic Vascular, INC. $16.46 2020
La Jolla Pharmaceutical Company $16.40 2022
Medtronic, INC. $14.53 2021
Amryt Pharma Holdings LTD $14.50 2021
Nuwellis, INC. $12.70 2019
Aegerion Pharmaceuticals, INC. $12.51 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Wilkett

$24,514.28

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $4,922 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/87238/david-wilkett

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.